Skip to main content
Advertisement

< Back to Article

A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

Table 5

Serum antibody response induced by a second 103 PFU dose of rDEN1Δ30 given at 4 or 6 months after first dose.

Table 5

doi: https://doi.org/10.1371/journal.pntd.0001267.t005